Johnson & Johnson
JNJ US
JNJ USJohnson & Johnson
USCompany Description
- CEO
- Mr. Joaquin Duato
- Full Time Employees
- 152,700
- Sector
- Healthcare
- Industry
- Drug Manufacturers—General
- Address
- One Johnson & Johnson Plaza New Brunswick NJ United States 08933
- IPO Date
- Jan 2, 1962
- CIK
- 0000200406
- Website
- www.jnj.com
- Business
- Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Company News
Blockbuster Cancer Treatment Stymied by Supply Chain—for Now
J&J Revamps Drug Research, Plots Medical Device Deals
Big Pharma’s Battle With the Biden Administration Could Have Legs
Kenvue Stock Falls 6%, Drops Below IPO Price
Healthcare Stocks Push the Dow Higher
Stock Market News
Cidara Shares Rally Premarket as J&J Moves Forward on Influenza Pact
J&J’s $40 Billion Split-Off Sets Stage for Pharma, Medical Tech Expansion
As Medicare drug-price negotiations inch forward, some states are flexing new powers to cut costs for a broader swath of drugs
J&J Dividend Decision Shows Power of Free Cash Flow
Health Care Roundup: Market Talk
Johnson & Johnson Maintains Dividend After Kenvue Spinout
Johnson & Johnson Revises 2Q Results After Kenvue Split
Johnson & Johnson Adjusts Full-Year Outlook to Reflect Kenvue Split
Crypto Scores Big Win Over the SEC. Why the Battle’s Far From Over.
Johnson & Johnson 2Q Adj EPS $2.56 >JNJ
Kenvue Fits Right In With Other Dividend Aristocrats
Expensive Drugs Targeted for First U.S. Price Negotiations
The Unexpected Bad News For Novo's Ozempic In Biden's Drug Negotiations List
First 10 Drugs Picked for Medicare Price Negotiations